approval · primary record
GARETOSMAB-GRTS
FDA · BLA · 2026-08-19
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-19 |
| Brand | PASATRU |
| Sponsor | REGENERON PHARMACEUTICALS, INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:31.840Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:GARETOSMAB-GRTS:2026-08-19
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Garetosmab-Grts · compound